A cold injection may cause brief stinging or discomfort at the injection site, while room-temperature medication typically feels less irritating
OASIS 3: A 44-week efficacy and safety phase 3a trial comparing once-daily oral semaglutide (50 mg) to placebo for weight loss in 200 Chinese adults with obesity or overweight with one or more comorbidities
Lautert-Dutra W, Melo CM, Chaves LP, Sousa FC, Crozier C, Dion D, Avante FS, Saggioro FP, Dos Reis RB, Archangelo LF
In the dispassionately scientific language of clinical trials, the stated aim of the study is to learn more about the effect of tirzepatide compared to semaglutide on the change in body weight in adults living with obesity or excess weight who have weight-related medical problems
Complete Wellness: Every ingredient supports multiple body systems simultaneouslyskin, energy, digestion, immunity, and mental clarity